[1]孙晓清a,崔照领b,刘晓旭c.子宫内膜异位症患者血清LncRNA NEAT1，miR-424-5p 水平表达与临床分期及不孕诊断的相关研究[J].现代检验医学杂志,2024,39(05):54-57+74.[doi:10.3969/j.issn.1671-7414.2024.05.010]
　SUN Xiaoqinga,CUI Zhaolingb,LIU Xiaoxuc.Correlation among Serum LncRNA NEAT1, miR-424-5p Levels, Clinical Stage and Infertility Diagnosis in Patients with Endometriosis[J].Journal of Modern Laboratory Medicine,2024,39(05):54-57+74.[doi:10.3969/j.issn.1671-7414.2024.05.010]
点击复制

子宫内膜异位症患者血清LncRNA NEAT1，miR-424-5p 水平表达与临床分期及不孕诊断的相关研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年05期
页码:
54-57+74
栏目:
论著
出版日期:
2024-09-15

文章信息/Info

Title:
Correlation among Serum LncRNA NEAT1, miR-424-5p Levels, Clinical Stage and Infertility Diagnosis in Patients with Endometriosis
文章编号:
1671-7414（2024）05-054-05
作者:
孙晓清a; 崔照领b; 刘晓旭c
（石家庄市妇幼保健院 a. 产六科；b. 妇产科；c. 妇二科，石家庄 050000）
Author(s):
SUN Xiaoqinga; CUI Zhaolingb; LIU Xiaoxuc
（a. the Six Department of Obstetrics；b. Department of Obstetrics and Gynecology；c. the Second Department of Obstetrics and Gynecology，Shijiazhuang Maternal and Child Health Hospital, Shijiazhuang 050000，China）
关键词:
子宫内膜异位症并发不孕; 长链非编码RNA 核富含丰富的转录本1; 微小RNA-424-5p
分类号:
R714.2；R392.11
DOI:
10.3969/j.issn.1671-7414.2024.05.010
文献标志码:
A
摘要:
目的 探讨长链非编码RNA 核富含丰富的转录本1（long non-coding RNA nuclear-enriched abundant transcript1，LncRNA NEAT1）, 微小RNA（microRNA，miR）-424-5p 对子宫内膜异位症（endometriosis，EM）并发不孕的诊断及对疾病分期的应用价值。方法 将2021 年10 月～ 2023 年10 月在石家庄市妇幼保健院就诊的232 例EM 患者作为研究对象，其中120 例为EM 并发不孕患者作为不孕组，另外112 例为单纯EM 患者作为对照组，不孕组根据美国r-AFS 分期标准将患者分为r-AFS Ⅰ～Ⅱ期（n=27）、r-AFS Ⅲ期（n=45）和r-AFS Ⅳ期（n=48）；采用qRT-PCR 法检测血清LncRNA NEAT1，miR-424-5p 的表达水平；受试者工作特征（ROC）曲线分析血清LncRNA NEAT1，miR-424-5p 诊断EM 并发不孕的价值；多因素Logistic 回归分析EM 并发不孕患病的影响因素；在TargetScanHuman 网站上进行LncRNA NEAT1 靶向miR-424-5p 的生物信息学分析；Pearson 法分析EM 并发不孕患者血清LncRNA NEAT1 与miR-424-5p 表达水平的相关性。结果 不孕组和对照组血清LncRNA NEAT1（1.16±0.15 vs 1.02±0.13）、盆腔术史比例（17.50%vs 1.79%）、miR-424-5p（0.92±0.11 vs 1.04±0.12）表达水平比较，差异具有统计学意义（t=7.753，16.018，7.974，均P ＜ 0.05）；r-AFS Ⅰ ~ Ⅱ，Ⅲ，Ⅳ期患者血清LncRNA NEAT1（1.05±0.10，1.14±0.14，1.24±0.19）依次升高，miR-424-5p（0.99±0.12，0.93±0.11，0.87±0.10）表达水平依次降低，差异具统计学意义（F=13.528，10.910，均P ＜ 0.05）；LncRNA NEAT1 与miR-424-5p 存在靶向关系，EM 并发不孕患者血清LncRNA NEAT1 与miR-424-5p 表达水平呈负相关（r=-0.431，P ＜ 0.05）。血清LncRNA NEAT1，miR-424-5p 及联合诊断EM 并发不孕的AUC 分别为0.782，0.719和0.835，二者联合诊断的AUC 优于各自单独检测（Z=2.625，3.861，P=0.009，0.001）；LncRNA NEAT1 是EM 并发不孕的危险因素，miR-424-5p 是保护因素（P ＜ 0.05）。结论 EM 并发不孕患者血清LncRNA NEAT1 表达水平升高，miR-424-5p 表达水平下降，二者与疾病分期和不孕的发生有关。
Abstract:
Objective To explore the diagnostic value of long non-coding RNA nuclear-enriched abundant transcript 1 (LncRNA NEAT1) and microRNA (miR) -424-5p in the diagnosis of endometriosis (EM) combined with infertility and its application value in disease staging. Methods A total of 232 EM patients who visited Shijiazhuang Maternal and Child Health Hospital from October 2021 to October 2023 were selected as the study subjects, 120 patients with EM combined with infertility were used as the infertility group, and 112 patients with pure EM were regarded as the control group. The infertility group was separated into r-AFS stages I~II (n=27), r-AFS stage III (n=45), and r-AFS stage IV (n=48) according to the American r-AFS staging standards, and qRT-PCR method was applied to detect the expression levels of serum LncRNA NEAT1 and miR-424-5p. Receiver operating characteristic (ROC) curve was applied to analyze the value of serum LncRNA NEAT1 and miR-424-5p in diagnosing EM combined with infertility, and multivariate Logistic regression was applied to analyze the influencing factors of EM combined with infertility. Bioinformatics analysis of LncRNA NEAT1 targeting miR-424-5p was performed on the TargetScanHuman website. Pearson method was applied to analyze the correlation between serum LncRNA NEAT1 and miR-424-5p expression levels in patients with EM combined with infertility. Results Differences of serum LncRNA NEAT1（1.16±0.15 vs 1.02±0.13）， pelvic surgery history ratio（17.50% vs 1.79%），miR-424-5p（0.92±0.11 vs 1.04±0.12）expression levels between infertility group and control group were significant，and the differences were significant(t=7.753，16.018，7.974，all P<0.05). Serum LncRNA NEAT1 (1.05±0.10, 1.14±0.14, 1.24±0.19) increased and miR-424-5p (0.99±0.12, 0.93±0.11, 0.87±0.10) decreased in r-AFS stage Ⅰ ~ Ⅱ , Ⅲ , Ⅳ patients, and the differences were significant (F=13.528，10.910，all P<0.05). There was a targeting relationship between LncRNA NEAT1 and miR-424-5p, and there was a negative correlation between serum LncRNA NEAT1 and miR-424-5p expression levels in EM patients with infertility (r=-0.431, P<0.05). The AUCs of serum LncRNA NEAT1, miR-424-5p, and combined diagnosis for EM combined with infertility were 0.782, 0.719 and 0.835, respectively, and the AUC of combined diagnosis was better than that of individual detection (Z=2.625, 3.861, P=0.009, 0.001). LncRNA NEAT1 was a risk factor for EM combined with infertility, while miR-424-5p was a protective factor (all P<0.05). Conclusion The expression level of serum LncRNA NEAT1 is increased and miR-424-5p is decreased in EM patients with infertility, both of which are related to the disease stage and the occurrence of infertility.

参考文献/References:

[1] CHAPRON C, MARCELLIN L, BORGHESE B, et al. Rethinking mechanisms, diagnosis and management of endometriosis[J]. Nature Reviews Endocrinology, 2019, 15(11): 666-682.
[2] BONAVINA G, TAYLOR H S. Endometriosisassociated infertility:from pathophysiology to tailored treatment[J]. Frontiers in Endocrinolog (Lau sanne), 2022, 13:1020827.
[3] HU Wanxue, XIE Qin, XU Yicong, et al. Integrated bioinformatics analysis reveals function and regulatory network of miR-200b-3p in endometriosis[J]. BioMed Research International, 2020, 2020: 3962953.
[4] LIN Chunli, ZENG Saili, LI Miaojie. MiR-424-5p combined with miR-17-5p has high diagnostic efficacy for endometriosis[J]. Archives of Gynecology and Obstetrics, 2023, 307(1): 169-177.
[5] 林勇清, 刘玥君, 张少芬, 等. 《2022 欧洲人类生殖与胚胎学学会子宫内膜异位症》指南解读[J]. 现代妇产科进展, 2023, 32(6): 452-454, 457. LIN Yongqing, LIU Yuejun, ZHANG Shaofen, et al. Interpretation of the 2022 European Society of Human Reproduction and Embryology Endometriosis guidelines[J]. Progress in Obstetrics and Gynecology, 2023, 32(6): 452-454, 457.
[6] SCHULTES G. Classification of endometriosis [J]. Wiener Medizinische Wochenschrift, 1999;149(13):361-365.
[7] TAYLOR H S, KOTLYAR A M, FLORES V A. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations[J]. Lancet, 2021, 397(10276): 839-852.
[8] BULUN S E, YILMAZ B D, SISON C, et al. Endometriosis[J]. Endocrine Reviews, 2019, 40(4): 1048-1079.
[9] ZHONG Qiyu, YANG Fan, CHEN Xiaochuan, et al. Patterns of immune infiltration in endometriosis and their relationship to r-AFS stages[J]. Frontiers in Genetics, 2021, 12: 631715.
[10] 曾辉苑, 张燕, 刘国栋, 等. 子宫内膜异位症患者血清中PAPP-A,IGF-I 水平及PAPP-A 基因rs7020782A/C 位点多态性与临床分期相关性研究[J]. 现代检验医学杂志, 2022, 37(1): 33-37. ZENG Huiyuan, ZHANG Yan, LIU Guodong, et al. Study on the correlation between the levels of PAPP-A, IGF-I and PAPP-A gene rs7020782 A/ C loci polymorphism and clinical stage in patients with endometriosis[J]. Journal of Modern Laboratory Medicine, 2022, 37(1): 33-37.
[11] ROLLA E. Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment[J]. F1000Research, 2019, 8: F1000 Faculty Rev- 529.
[12] CHEN Yuanyuan, LI Zhaojun, CHEN Xiaoguang, et al. Long non-coding RNAs: from disease code to drug role[J]. Acta Pharmaceutica Sinica. B, 2021, 11(2): 340-354.
[13] JING Dehuai, ZHU Fengqin, XU Zhen, et al. The role of long noncoding RNA (LncRNA) nuclear-enriched abundant transcript 1 (NEAT1) in immune diseases[J]. Transplant Immunology, 2022, 75: 101716.
[14] WANG Ziqiang, LI Kun, HUANG Weiren. Long non-coding RNA NEAT1-centric gene regulation[J]. Cellular and Molecular Life Sciences, 2020, 77(19): 3769-3779.
[15] YUAN Donglan, ZHU Dandan, YIN Boyu, et al. Expression of LncRNA NEAT1 in endometriosis and its biological functions in ectopic endometrial cells as mediated via miR-124-3p[J]. Genes & Genomics, 2022, 44(5): 527-537.
[16] LI Lingchuan, YE Kefan, WANG Dongjie. Upregulation of HTRA1 mediated by the LncRNA NEAT1/miR- 141-3p axis contributes to endometriosis development through activating NLRP3 inflammasome-mediated pyroptotic cell death and cellular inflammation[J]. In Vitro Cellular & Developmental Biology. Animal, 2023, 59(3): 166-178.
[17] TAHERI M, ASKARI A, HUSSEN B M, et al. Role of MAGI2-AS3 in malignant and non-malignant disorders[J]. Pathology Research and Practice, 2023, 246: 154530.
[18] WANG Sixue, YI Mingyu, ZHANG Xinyue, et al. Effects of CDKN2B-AS1 on cellular proliferation, invasion and AKT3 expression are attenuated by miR-424-5p in a model of ovarian endometriosis[J]. Reproductive Biomedicine Online, 2021, 42(6): 1057-1066.
[19] HUAN Qing, CHENG Shuchao, DU Zhanhui, et al. LncRNA AFAP1-AS1 regulates proliferation and apoptosis of endometriosis through activating STAT3/ TGF-β/Smad signaling via miR-424-5p[J]. Journal of Obstetrics and Gynaecology Research, 2021, 47(7): 2394-2405.
[20] MAO Haiyan, ZHANG Xiaohua, YIN Lu, et al. Silencing of circ_0007299 suppresses proliferation, migration, and invasiveness and promotes apoptosis of ectopic endometrial stromal cells in endometriosis via miR-424- 5p-dependent modulation of CREB1[J]. Archives of Gynecology and Obstetrics, 2023, 307(1): 149-161.

备注/Memo

备注/Memo:
基金项目：河北省卫生健康委员会资助项目（20240735）。
作者简介：孙晓清（1982-），女，本科，副主任医师，研究方向：妇科肿瘤，E-mail：e27ujm@163.com。
通讯作者：刘晓旭（1984-），女，博士，副主任医师，研究方向：妇科肿瘤，E-mail：c86uas@163.com。
更新日期/Last Update: 2024-09-15